G. Giaroli

发表

Ketamine as the prototype glutamatergic antidepressant: pharmacodynamic actions, and a systematic review and meta-analysis of efficacy

S. Shergill, C. Caddy, G. Giaroli, 2014, Therapeutic advances in psychopharmacology.

Performance of the Italian Version of the Subjective Well-being under Neuroleptic (SWN) Scale in Schizophrenic Outpatients

G. Giaroli, C. Bellantuono, M. Balestrieri, 2006, Pharmacopsychiatry.

To sleep or not to sleep: a systematic review of the literature of pharmacological treatments of insomnia in children and adolescents with attention-deficit/hyperactivity disorder.

G. Giaroli, D. Tracy, J. R. Barrett, 2013, Journal of child and adolescent psychopharmacology.

Does rare matter? Copy number variants at 16p11.2 and the risk of psychosis: A systematic review of literature and meta-analysis

A. McQuillin, N. Bass, G. Giaroli, 2014, Schizophrenia Research.

Exome sequence analysis and follow up genotyping implicates rare ULK1 variants to be involved in susceptibility to schizophrenia

A. McQuillin, N. Bass, D. Curtis, 2017, Annals of human genetics.

What Future Role Might N-Acetyl-Cysteine Have in the Treatment of Obsessive Compulsive and Grooming Disorders?: A Systematic Review

G. Giaroli, D. Tracy, Louise Smith, 2016, Journal of clinical psychopharmacology.

The use of antipsychotics in preschoolers: A veto or a sensible last option?

G. Giaroli, D. Tracy, Jessica Memarzia, 2014, Journal of psychopharmacology.

Dementia praecox redux: A systematic review of the nicotinic receptor as a target for cognitive symptoms of schizophrenia

S. Shergill, G. Giaroli, D. Tracy, 2015, Journal of psychopharmacology.

Drug Attitude in Adolescents: A Key Factor for a Comprehensive Assessment

G. Giaroli, U. Balottin, G. Rossi, 2014, Journal of clinical psychopharmacology.

Taking the fuel out of the fire: evidence for the use of anti-inflammatory agents in the treatment of bipolar disorders.

G. Giaroli, D. Tracy, D. Baumeister, 2015, Journal of affective disorders.

Predictive power of the ADHD GWAS 2019 polygenic risk scores in independent samples of bipolar patients with childhood ADHD.

M. Nöthen, A. McQuillin, N. Bass, 2019, Journal of affective disorders.

Bipolar depression: clinically missed, pharmacologically mismanaged

G. Giaroli, D. Tracy, David Taylor, 2011, Therapeutic advances in psychopharmacology.

Beyond Dopamine: Glutamate as a Target for Future Antipsychotics

G. Giaroli, D. Tracy, K. Sendt, 2012, ISRN pharmacology.

What future role might N-acetyl-cysteine have in the treatment of Obsessive Compulsive Spectrum disorders? A systematic review

G. Giaroli, D. Tracy, Louise Smith, 2015 .

Prevalence of attention deficit hyperactivity disorder symptoms in patients with schizophrenia

A. McQuillin, G. Giaroli, K. Wolfe, 2018, Acta psychiatrica Scandinavica.

Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles

G. Giaroli, D. Tracy, D. Baumeister, 2014, Therapeutic advances in psychopharmacology.

Beyond Dopamine: Glutamate as a Target for Future Antipsychotics

G. Giaroli, D. Tracy, Kyra-Verena Sendt, 2012 .